Cargando…
Response to intravenous bisphosphonate therapy in hypercalcaemic patients with and without bone metastases: the role of parathyroid hormone-related protein.
Plasma parathyroid hormone related-protein (PTHrP) may inhibit the calcium-lowering effect of bisphosphonate therapy. In this prospective study we examined the relationship between plasma PTHrP levels, renal tubular markers of calcium reabsorption, and the effectiveness of intravenous bisphosphonate...
Autores principales: | Walls, J., Ratcliffe, W. A., Howell, A., Bundred, N. J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1994
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033320/ https://www.ncbi.nlm.nih.gov/pubmed/8018531 |
Ejemplares similares
-
Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988) -
Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases
por: Walls, J, et al.
Publicado: (1999) -
Parathyroid carcinoma with pancreatitis causing hypercalcaemic emergency treated with extracorporeal membrane oxygenation-assisted parathyroid resection
por: Toyoda, Madoka, et al.
Publicado: (2022) -
Bone resorption and acute renal failure in the hypercalcaemic critically ill
por: Ledson, JF, et al.
Publicado: (2001) -
The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells
por: Hoey, R P, et al.
Publicado: (2003)